Lawyers seeking to create a $1 billion medical monitoring trust for babies born addicted to opioids lost their bid to create a separate multidistrict litigation proceeding.

The U.S. Judicial Panel on Multidistrict Litigation in an order Thursday refused to transfer class actions brought on behalf of 40 percent of the nation’s opioid-addicted babies, the latest group of plaintiffs suing manufacturers and distributors over a nationwide epidemic tied to the prescription painkillers. The panel concluded that there would be “substantial overlap” with the multidistrict litigation it created a year ago for opioid lawsuits.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]